Artelo Biosciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

COMMITMENTS AND CONTINGENCIES

6 Months Ended

Feb. 28, 2019

NOTE 6 – COMMITMENTS AND CONTINGENCIES

The Company has certain financial commitments in relation to Research and Development contracts. As of February 28, 2019:

	·	The Company is obligated to make one payment of $77,760 on March 1, 2019 for research and development.
	·	The Company is obligated to make two semi-annual payments totaling 115,000 GBP over the next year. A payment of $57,500 GBP is due on October 5, 2018, and April 5, 2019, respectively. The October 5, 2018 payment has not yet been paid by the Company.
	·	The Company is invoiced monthly and quarterly in relation to several Research and Development contracts.
	·	The Company may be obligated to make additional payments related to Research and Development contracts entered into, dependent on the progress and milestones achieved through the programs.